Figure 2From: Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort studyA: Risk of cardiovascular mortality and non-fatal myocardial infarction (MI), B: risk of cardiovascular mortality, and C: risk of all-cause mortality associated with glucose-lowering drug monotherapy. Time-dependent Cox analyses were performed with adjustments for age, sex, socioeconomic status, calendar year, concomitant medication and co-morbidity. Analyses for both individual sulfonylureas and sulfonylureas grouped as one pharmacological class were performed.Back to article page